Good MorningEquity markets continued to advance on Tuesday, although the pace of gains slowed. The S&P 500 advanced 0.20% after tepid results from blue-chip giant Walt Disney and others sapped enthusiasm for risk-on assets. Walt Disney reported good results but in alignment with expectations, giving no catalyst for a rally. The S&P may continue higher over the next few trading sessions but there is risk of slowing momentum and topping out near the all-time highs.
The next major hurdles for the market will come next week. The CPI data is due on Wednesday and is unlikely to alter the Fed outlook. Earnings reports from the retail sector are another hurdle for equities. Reports from leaders like Walmart and Home Depot are due early in the week and may provide an unwanted surprise. Reports from McDonald's, Coca-Cola, Kraft Heinz, and Starbucks reveal a pinched consumer that may show in the retail results. Investors should expect weakness generally and market-leading strength from the off-price segment. Featured: Gold’s Price Surge: What It Means for You (Priority Gold) 
|
Markets | | | The latest ISM manufacturing PMI index suggests that the turning point for the automotive stock sector is imminent. According to the report, a member of the primary metals industry was quoted as saying that "automotive builds continue at averages but not near maximum outputs." This could transl... Read the Full Story |
|
From Our PartnersOne of America’s top commodities experts just stopped by Alabama’s biggest fusion energy plant today to share some very important news with you…
One that has to do with the state of the global energy markets… And how our nation's national security might be on the line if we don’t act now…
You see, this critical resource is running very low.
And what little is left is being stockpiled by government agencies around the world at the fastest pace in decades.
This could lead to a repeat of this energy resource’s BOOM period like we saw in the 2000s…
When top stocks skyrocketed as much as 3,379%, 5,973% even 9,149% in a few short years.
Or it could be much, much bigger.
Don’t be left out if that happens. | | | | Go here to get the details. |
|
Markets | | | Asian markets were mostly higher Tuesday after another day of gains on Wall Street, although Chinese shares faltered. U.S. futures and oil prices edged higher. Tokyo's Nikkei 225, reopening after a national holiday, jumped 1.5% to 38,784.91 and the Kospi in South Korea surged 1.9% to 2,728.05. Hong ... Read the Full Story |
|
Markets | | | This year's Berkshire Hathaway meeting gave shareholders their best chance yet to hear from the man who will one day take over as CEO when Warren Buffett is gone, but Buffett said for the first time Saturday that Greg Abel should also take responsibility for the company's investments after he takes ... Read the Full Story |
|
|
Markets | | | Warren Buffett cautioned the tens of thousands of shareholders who packed an arena for his annual meeting that artificial intelligence scams could become "the growth industry of all time."Doubling down on his cautionary words from last year, Buffett told the throngs he recently came face to face wit... Read the Full Story |
|
Stocks | | | Berkshire Hathaway's first quarter profits plummeted along with the paper value of its investments, but the company said Saturday that most of the businesses it owns outright performed well.The company reported reported a $12.7 billion profit, or $8.825 per Class A share, in the quarter. That’s roug... Read the Full Story |
|
From Our PartnersThere's no shortage of controversial CEOs in America today...
From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon...
But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1... | | | | Don't miss Porter's brand-new presentation on this subject |
|
Tech | | | Upwork Inc. (NASDAQ: UPWK) is the largest online freelancer platform in the world, with over 870,000 active clients. The computer and technology sector giant has been making a concentrated push to become a top artificial intelligence (AI) freelance work hub, partnering with OpenAI, GoDaddy Inc. (NYS... Read the Full Story |
|
Markets | | | Social commerce platform Pinterest Inc. (NYSE: PINS) shares are climbing towards 52-week highs on the heels of a spectacular Q1 2024 earnings report. The rebound in the advertising market, coupled with its artificial intelligence (AI) powered personalization and shop-ability effects, bolstered the c... Read the Full Story |
|
Markets | | |
Shares of AbbVie (NYSE: ABBV) fell hard in the wake of its Q1 earnings report, but the dip is over. The market response to slowing Humira sales is overshadowed by strength in the non-Humira portfolio, resilient business, and a solid pipeline. Analysts trimmed their targets following the release, b... Read the Full Story |
|
Markets | | | The Walt Disney Co. moved to a loss in its second quarter, hampered by significantly higher restructuring and impairment charges, but its adjusted profit topped Wall Street’s view and its streaming business was profitable Read the Full Story |
|
Tech | | | Garmin Ltd. (NYSE: GRMN) launched in 1989 with the sole focus of providing GPS devices for consumers. Years later, the advent of smartphone GPS apps like Google Maps, Apple Maps, and Waze could have spelled death for the company. However, the computer and technology sector giant has thrived by branc... Read the Full Story |
|
Wednesday's Early Bird Stock Of The Day Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets in the United States, the United Kingdom, rest of Europe, Middle East, and Africa, Greater China, rest of Asia-Pacific, and internationally. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. | | View Today's Stock Pick |
|
